DAUNORUBICIN HYDROCHLORIDE vs KOMZIFTI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. DAUNORUBICIN HYDROCHLORIDE and KOMZIFTI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DAUNORUBICIN HYDROCHLORIDE	KOMZIFTI
Rating	66/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	DAUNORUBICIN HYDROCHLORIDE	ZIFTOMENIB
Manufacturer	Fresenius Kabi USA	Kura
Dosage forms	Injectable, Solution	Capsule
Drug class	Anthracycline Topoisomerase Inhibitor	—
Boxed warning	None	Boxed warning
Treats	Acute Myeloid Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma	Acute Myeloid Leukemia

daunorubicin hydrochloride komzifti

Rating

66/100

New

Pharmacy pays

—

Type

Active ingredient

DAUNORUBICIN HYDROCHLORIDE

ZIFTOMENIB

Manufacturer

Fresenius Kabi USA

Kura

Dosage forms

Injectable, Solution

Capsule

Drug class

Anthracycline Topoisomerase Inhibitor

—

Boxed warning

None

Boxed warning

Treats

Acute Myeloid Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Acute Myeloid Leukemia

Frequently asked questions

What is the difference between Daunorubicin Hydrochloride and Komzifti?

Daunorubicin Hydrochloride contains Daunorubicin Hydrochloride, while Komzifti contains Ziftomenib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.